Clarity strengthens Cu-64 network with new supply agreement

• Agreement with SpectronRx ensures seamless supply of the diagnostic copper-64 (Cu-64 or Cu) isotope for Clarity’s products which continue to progress through clinical trials, including a pivotal Phase III clinical trial. • Cu-64 has an ideal 12.7-hour half-life that helps to overcome the overwhelming supply restraints of current-generation radiodiagnostics based on gallium-68 (Ga-68) with a half